Title : Long-term treatment study of global standard dose metformin in Japanese patients with type 2 diabetes mellitus.

Pub. Date : 2017 Aug

PMID : 30603334






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The changes in HbA1c from baseline to the final evaluation visit were -1.32 +- 0.76% for metformin monotherapy and -1.29 +- 0.81% for metformin plus SU, both significantly lower than baseline. Metformin hemoglobin subunit alpha 1 Homo sapiens
2 The changes in HbA1c from baseline to the final evaluation visit were -1.32 +- 0.76% for metformin monotherapy and -1.29 +- 0.81% for metformin plus SU, both significantly lower than baseline. Metformin hemoglobin subunit alpha 1 Homo sapiens